Equities analysts expect Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Rating) to report sales of $870.80 million for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Calumet Specialty Products Partners’ earnings. The lowest sales estimate is $856.70 million and the highest is $884.90 million. Calumet Specialty Products Partners posted sales of $600.30 million during the same quarter last year, which suggests a positive year-over-year growth rate of 45.1%. The firm is expected to report its next quarterly earnings results before the market opens on Monday, January 1st.
According to Zacks, analysts expect that Calumet Specialty Products Partners will report full year sales of $3.54 billion for the current year, with estimates ranging from $3.45 billion to $3.64 billion. For the next financial year, analysts forecast that the company will post sales of $4.14 billion, with estimates ranging from $3.99 billion to $4.28 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Calumet Specialty Products Partners.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Rating) last posted its earnings results on Friday, February 25th. The oil and gas company reported ($1.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by ($0.73). The firm had revenue of $865.80 million during the quarter, compared to the consensus estimate of $810.85 million. During the same period in the previous year, the business earned ($1.03) earnings per share.
Several institutional investors and hedge funds have recently modified their holdings of the company. Knott David M boosted its holdings in shares of Calumet Specialty Products Partners by 13.1% during the 3rd quarter. Knott David M now owns 3,567,500 shares of the oil and gas company’s stock worth $28,219,000 after buying an additional 414,200 shares during the period. Barclays PLC lifted its holdings in shares of Calumet Specialty Products Partners by 16,848.0% during the third quarter. Barclays PLC now owns 137,109 shares of the oil and gas company’s stock worth $1,085,000 after buying an additional 136,300 shares in the last quarter. Adams Asset Advisors LLC grew its stake in shares of Calumet Specialty Products Partners by 1.4% in the fourth quarter. Adams Asset Advisors LLC now owns 5,222,003 shares of the oil and gas company’s stock valued at $68,930,000 after acquiring an additional 72,785 shares in the last quarter. Raymond James & Associates increased its holdings in shares of Calumet Specialty Products Partners by 39.5% during the third quarter. Raymond James & Associates now owns 211,061 shares of the oil and gas company’s stock worth $1,669,000 after purchasing an additional 59,809 shares during the period. Finally, Bank of Montreal Can acquired a new position in Calumet Specialty Products Partners in the fourth quarter valued at about $760,000. 31.49% of the stock is currently owned by institutional investors.
CLMT opened at $15.25 on Friday. Calumet Specialty Products Partners has a one year low of $5.27 and a one year high of $17.43. The stock’s fifty day moving average is $14.13 and its 200-day moving average is $13.87. The company has a market capitalization of $1.20 billion, a PE ratio of -4.72 and a beta of 2.33.
About Calumet Specialty Products Partners (Get Rating)
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.
- Get a free copy of the StockNews.com research report on Calumet Specialty Products Partners (CLMT)
- O’Reilly Automotive Hits A Pothole
- Iridium Communications Stock is Ready to Return to Orbit
- There’s An Institutional Floor In Keurig Dr. Pepper
- Ford Falls Despite Optimistic Outlook
- Harley-Davidson Skids Into A Buying Opportunity
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.